Asuragen Launches Powerful New microRNA Analysis Tool.First Generation Array Content Probes Over 13,000 Candidate miRNAs AUSTIN, Texas -- Asuragen, Inc., a molecular biology molecular biology, scientific study of the molecular basis of life processes, including cellular respiration, excretion, and reproduction. The term molecular biology was coined in 1938 by Warren Weaver, then director of the natural sciences program at the Rockefeller service provider and oncology molecular diagnostic company, announced today the launch of its new high-content microRNA (miRNA) service. The service enables comprehensive analysis of miRNA expression profiles from published miRNA sequences and a vastly expanded set of unpublished candidate miRNAs. The first generation platform for Asuragen's DiscovArray(SM) miRNA Expression Service uses a new Ambion array that is custom-manufactured by Affymetrix([R]) and designed specifically for miRNA expression analysis. Currently available only through Asuragen Services, the array contains features representing validated Sanger miRBase content in combination with over 12,000 exploratory human miRNAs. The robustness of the Affymetrix platform and Asuragen's highly sensitive Adj. 1. highly sensitive - readily affected by various agents; "a highly sensitive explosive is easily exploded by a shock"; "a sensitive colloid is readily coagulated" labeling technology combined with miRInform[TM], a new web-enabled data delivery system from Asuragen, offer unprecedented data quality and value to anyone studying miRNAs. "The DiscovArray service provides a dramatically expanded view in potential miRNAs on the gold-standard Affymetrix platform," commented Scott Hunicke-Smith, V.P. and General Manager of Asuragen Services. "Data analysis is delivered so that results can be understood within minutes, and is priced to encourage researchers to build more power into their studies within a given budget." "Data quality is paramount to us and our customers. The reproducibility, sensitivity, and content represented in the DiscovArray service along with Asuragen's experience in miRNA research allows us to offer outstanding miRNA data quality," added Greg Kinch, Director of Sales and Marketing for Asuragen Services. Asuragen, a cGMP/cGLP company, is dedicated to development of new products for miRNA discovery and the advancement of RNA-based science in the field of disease management. About Asuragen, Inc. Asuragen is a molecular biology service provider and fully integrated diagnostic reagent company focused on molecular oncology and early detection of cancer, with emphasis on miRNA. Asuragen Services provides a comprehensive range of molecular services enabling scientists to make more informed and reliable decisions. Asuragen's expertise in RNA RNA: see nucleic acid. RNA in full ribonucleic acid One of the two main types of nucleic acid (the other being DNA), which functions in cellular protein synthesis in all living cells and replaces DNA as the carrier of genetic serves as a focal point focal point n. See focus. for all of its services, including Gene Expression Profiling Microarray technology is often used for gene expression profiling. It makes use of the sequence resources created by the genome sequencing projects and other sequencing efforts to answer the question, , microRNA Expression Profiling, data analysis and bioinformatics support, and nucleic acid nucleic acid, any of a group of organic substances found in the chromosomes of living cells and viruses that play a central role in the storage and replication of hereditary information and in the expression of this information through protein synthesis. isolation. Asuragen's cGLP services are suitable for clinical research studies, pharmacogenomics Pharmacogenomics is the branch of pharmacology which deals with the influence of genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with a drug's efficacy or toxicity. , and biomarker discovery Biomarker discovery is the process by which biomarkers are discovered. It is a medical term. Many commonly used blood tests in medicine are biomarkers. The way that these tests have been found can be seen as biomarker discovery. . For more information, please visit www.asuragen.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion